Reid P. Bissonnette,Alain Rolland,Mireille Gillings
申请号：
US16541007
公开号：
US20200172621A1
申请日:
2019.08.14
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are combinations that include an HDACi and a PD-1 inhibitor that are useful for treating cancer, including reducing and/or preventing cancer metastasis. The combination is also useful for treating cancer that has been previously treated with a PD-L1 inhibitor.
